Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (491-500 of 567) with videos related to

Pageof 57
Sort By:
Cytometry. Part B, Clinical Cytometry|September 26, 2022
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursorsHong Fang, Sa A Wang, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Genetic Vaccines and Therapy|June 20, 2012
An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic deliveryNi-Chung Lee, Darin J Falk, Barry J Byrne, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell LymphomaJuliana E Hidalgo Lopez, Mariko Yabe, Adrian A Carballo-Zarate, et al.
European Journal of Endocrinology|August 23, 2021
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancyA Luger, L H A Broersen, N R Biermasz, et al.
Journal of Chemical Theory and Computation|November 20, 2015
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and ProteinsEdward Harder, Wolfgang Damm, Jon Maple, et al.
American Journal of Hematology|January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remissionNaveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
Pageof 57

Showing results (491-500 of 567) with videos related to

Sort By:
Pageof 57
Cytometry. Part B, Clinical Cytometry|September 26, 2022
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursorsHong Fang, Sa A Wang, M James You, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 7, 2017
CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical courseZhihong Hu, Yi Sun, Ellen J Schlette, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2010
Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemiaDeborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2017
Morphologic and Molecular Characteristics of De Novo AML With <i>JAK2</i> V617F MutationJuliana E Hidalgo-López, Rashmi Kanagal-Shamanna, L Jeffrey Medeiros, et al.
Genetic Vaccines and Therapy|June 20, 2012
An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic deliveryNi-Chung Lee, Darin J Falk, Barry J Byrne, et al.
Haematologica|October 27, 2018
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemiaEvgeniya Angelova, Charlene Audette, Yelena Kovtun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell LymphomaJuliana E Hidalgo Lopez, Mariko Yabe, Adrian A Carballo-Zarate, et al.
European Journal of Endocrinology|August 23, 2021
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancyA Luger, L H A Broersen, N R Biermasz, et al.
Journal of Chemical Theory and Computation|November 20, 2015
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and ProteinsEdward Harder, Wolfgang Damm, Jon Maple, et al.
American Journal of Hematology|January 5, 2017
Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remissionNaveen Pemmaraju, Hagop Kantarjian, Jeffrey L Jorgensen, et al.
Pageof 57